These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37976549)

  • 21. Brain Network Alterations in Alzheimer's Disease Identified by Early-Phase PIB-PET.
    Fu L; Liu L; Zhang J; Xu B; Fan Y; Tian J
    Contrast Media Mol Imaging; 2018; 2018():6830105. PubMed ID: 29531506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 3D convolutional neural network to classify subjects as Alzheimer's disease, frontotemporal dementia or healthy controls using brain 18F-FDG PET.
    Rogeau A; Hives F; Bordier C; Lahousse H; Roca V; Lebouvier T; Pasquier F; Huglo D; Semah F; Lopes R
    Neuroimage; 2024 Mar; 288():120530. PubMed ID: 38311126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal FDG-PET features for the classification of Alzheimer's disease.
    Rodrigues F; Silveira M
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():1941-4. PubMed ID: 25570360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data.
    Sekine T; Buck A; Delso G; Kemp B; Ter Voert EEGW; Huellner M; Veit-Haibach P; Kaushik S; Wiesinger F; Warnock G;
    PLoS One; 2020; 15(6):e0233886. PubMed ID: 32492074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
    Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
    Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Voxel-based classification of FDG PET in dementia using inter-scanner normalization.
    Thiele F; Young S; Buchert R; Wenzel F
    Neuroimage; 2013 Aug; 77():62-9. PubMed ID: 23541799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study.
    Takahashi R; Ishii K; Senda M; Ito K; Ishii K; Kato T; Makishi Y; Nishio T; Ikari Y; Iwatsubo T;
    Ann Nucl Med; 2013 Jun; 27(5):452-9. PubMed ID: 23483370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The congruency of neuropsychological and F18-FDG brain PET/CT diagnostics of Alzheimer's Disease (AD) in routine clinical practice: insights from a mixed neurological patient cohort.
    Hansen S; Keune J; Küfner K; Meister R; Habich J; Koska J; Förster S; Oschmann P; Keune PM
    BMC Neurol; 2022 Mar; 22(1):83. PubMed ID: 35264143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
    Inui Y; Ito K; Kato T;
    J Alzheimers Dis; 2017; 60(3):877-887. PubMed ID: 28922157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Support vector machine-based classification of neuroimages in Alzheimer's disease: direct comparison of FDG-PET, rCBF-SPECT and MRI data acquired from the same individuals.
    Ferreira LK; Rondina JM; Kubo R; Ono CR; Leite CC; Smid J; Bottino C; Nitrini R; Busatto GF; Duran FL; Buchpiguel CA
    Braz J Psychiatry; 2018; 40(2):181-191. PubMed ID: 28977066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an age-mismatched and sex-mismatched normal database on the diagnostic performance of ¹⁸F-FDG PET for Alzheimer's disease: the Ishikawa Brain Imaging Study.
    Chen WP; Samuraki M; Shima K; Yanase D; Takeda N; Miyazaki Y; Ono K; Yoshita M; Nishimura S; Yamada M; Matsunari I
    Nucl Med Commun; 2011 Dec; 32(12):1128-33. PubMed ID: 21934543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation.
    Yamane T; Ikari Y; Nishio T; Ishii K; Ishii K; Kato T; Ito K; Silverman DH; Senda M; Asada T; Arai H; Sugishita M; Iwatsubo T;
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):244-9. PubMed ID: 23907243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study.
    Mosconi L; Murray J; Davies M; Williams S; Pirraglia E; Spector N; Tsui WH; Li Y; Butler T; Osorio RS; Glodzik L; Vallabhajosula S; McHugh P; Marmar CR; de Leon MJ
    BMJ Open; 2014 Jun; 4(6):e004850. PubMed ID: 24961717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.
    De Carli F; Nobili F; Pagani M; Bauckneht M; Massa F; Grazzini M; Jonsson C; Peira E; Morbelli S; Arnaldi D;
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):334-347. PubMed ID: 30382303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study.
    Ou YN; Xu W; Li JQ; Guo Y; Cui M; Chen KL; Huang YY; Dong Q; Tan L; Yu JT;
    Alzheimers Res Ther; 2019 Jun; 11(1):57. PubMed ID: 31253185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.